Literature DB >> 33460569

Assessing the importance of interleukin-6 in COVID-19.

Luke Y C Chen1, Ryan L Hoiland2, Sophie Stukas3, Cheryl L Wellington3, Mypinder S Sekhon4.   

Abstract

Entities:  

Year:  2021        PMID： 33460569     DOI： 10.1016/S2213-2600(20)30600-7

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  19 in total

Review 1.  Pediatric Inflammatory Multisystem Syndrome (PIMS) - Potential role for cytokines such Is IL-6.

Authors:  L Lacina; J Brábek; Š Fingerhutová; J Zeman; K Smetana
Journal:  Physiol Res       Date:  2021-04-30       Impact factor: 1.881

2.  A Multimodal Approach for the Risk Prediction of Intensive Care and Mortality in Patients with COVID-19.

Authors:  Vasileios C Pezoulas; Konstantina D Kourou; Costas Papaloukas; Vassiliki Triantafyllia; Vicky Lampropoulou; Eleni Siouti; Maria Papadaki; Maria Salagianni; Evangelia Koukaki; Nikoletta Rovina; Antonia Koutsoukou; Evangelos Andreakos; Dimitrios I Fotiadis
Journal:  Diagnostics (Basel)       Date:  2021-12-28

Review 3.  The immunology and immunotherapy for COVID-19.

Authors:  Yixin Liu; Xinsheng Zhou; Xuan Liu; Xiaotao Jiang
Journal:  Expert Rev Mol Med       Date:  2021-12-17       Impact factor: 7.615

4.  A Novel Humanized Anti-Interleukin-6 Antibody HZ0408b With Anti-Rheumatoid Arthritis Therapeutic Potential.

Authors:  Xiaolei Liu; Li Li; Qian Wang; Fengchao Jiang; Pei Zhang; Fei Guo; Hongjun Liu; Jian Huang
Journal:  Front Immunol       Date:  2022-01-19       Impact factor: 7.561

5.  Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.

Authors:  Olga Krysko; Elena Kondakova; Olga Vershinina; Elena Galova; Anna Blagonravova; Ekaterina Gorshkova; Claus Bachert; Mikhail Ivanchenko; Dmitri V Krysko; Maria Vedunova
Journal:  Front Immunol       Date:  2021-08-27       Impact factor: 7.561

Review 6.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review.

Authors:  Thomas Köhler; Elke Schwier; Janina Praxenthaler; Carmen Kirchner; Dietrich Henzler; Claas Eickmeyer
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

7.  Time-to-event assessment for the discovery of the proper prognostic value of clinical biomarkers optimized for COVID-19.

Authors:  José Raniery Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2022-02-04       Impact factor: 2.365

8.  A case of successive development of possible acute necrotizing encephalopathy after COVID-19 pneumonia.

Authors:  Pasin Hemachudha; Thanakit Pongpitakmetha; Wanakorn Rattanawong; Poosanu Thanapornsungsuth; Yutthana Joyjinda; Saowalak Bunprakob; Chanida Ruchisrisarod; Thiravat Hemachudha
Journal:  SAGE Open Med Case Rep       Date:  2022-03-15

Review 9.  Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?

Authors:  A Costanza; A Amerio; A Aguglia; G Serafini; M Amore; R Hasler; J Ambrosetti; G Bondolfi; G Sampogna; I Berardelli; A Fiorillo; M Pompili; K D Nguyen
Journal:  Neurosci Biobehav Rev       Date:  2022-03-12       Impact factor: 9.052

10.  In Vivo Hematopoietic Stem Cell Gene Therapy for SARS-CoV2 Infection Using a Decoy Receptor.

Authors:  Hongjie Wang; Chang Li; Adebimpe O Obadan; Hannah Frizzell; Tien-Ying Hsiang; Sucheol Gil; Audrey Germond; Connie Fountain; Audrey Baldessari; Steve Roffler; Hans-Peter Kiem; Deborah H Fuller; André Lieber
Journal:  Hum Gene Ther       Date:  2022-04       Impact factor: 4.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.